Notice2022-20842
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 27, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 186 (Tuesday, September 27, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 186 (Tuesday, September 27, 2022)]
[Notices]
[Page 58506]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-20842]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: October 18, 2022.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W542, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Biman Chandra Paria, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W542, Rockville, Maryland 20850, 240-858-3814,
<a href="/cdn-cgi/l/email-protection#b3c3d2c1dad2d1f3ded2dadf9ddddadb9dd4dcc5"><span class="__cf_email__" data-cfemail="aadacbd8c3cbc8eac7cbc3c684c4c3c284cdc5dc">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Small Business Transition Grants for Early Career Scientists.
Date: November 9, 2022.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#31424442505f1f4241545f5254715f58591f565e47"><span class="__cf_email__" data-cfemail="0a797f796b6424797a6f64696f4a646362246d657c">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review.
Date: November 17, 2022.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W618, Rockville, Maryland 20850, 240-276-6611,
<a href="/cdn-cgi/l/email-protection#59342c323c2a3177322c34382b6a19373031773e362f"><span class="__cf_email__" data-cfemail="523f273937213a7c39273f332061123c3b3a7c353d24">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20842 Filed 9-26-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 27, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.